Cancer Chemother Pharmacol
Antineoplastic Combined Chemotherapy ProtocolsATP Binding Cassette Transporter, Subfamily B, Member 1Cytarabine
Dr. Branimir I. Sikic, MD
NPI1376679548
- Publications
- 181
- Clinical trials
- 8
- Industry payments
- $20,855
- State license
- 1
- Year NPI issued
- 2007
- Practice address
- 300 Pasteur Dr, Stanford, CA 94305
- Practice phone
- Call (650) 723-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Stanford Hospital
Stanford, California
Find Dr. Sikic's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Branimir I. Sikic is a hematologist and oncologist in Stanford, California
Dr. Sikic practices at Stanford Hospital in Stanford, California.
Dr. Sikic's NPI, 1376679548, was assigned on February 24, 2007. Dr. Sikic graduated from Pritzker School of Medicine in 1972. Dr. Sikic's California license number on file is G41273.
NPI and contact details
- NPI
- 1376679548NPI Registry (opens in a new tab)
- NPI enumeration date
- February 24, 2007
- NPI status
- Active
- Practice phone
- (650) 723-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1972
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Branimir I. Sikic practices at Stanford Hospital in Stanford, California
Dr. Sikic's primary practice is Stanford Hospital, at 300 Pasteur Dr, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.
- Stanford Hospital300 Pasteur Dr, Stanford, CA 94305 · Santa Clara CountyPhone(650) 723-4000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Branimir I. Sikic is affiliated with 1 site of care
Dr. Sikic's primary practice is Stanford Hospital in Stanford, California.
Stanford HospitalPrimary
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Branimir I. Sikic's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sikic practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Stanford Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Sikic practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Branimir I. Sikic is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Sikic's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sikic is board certified in internal medicine by the American Board of Internal Medicine. Dr. Sikic has a license on file in California.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
Hematologists and oncologists near Dr. Sikic
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Branimir I. Sikic has 181 publications on record
Dmand AI links 181 papers to Dr. Sikic, published from 2000 to 2024. 2014 was the busiest year, with 6. The most frequent topics are ATP Binding Cassette Transporter, Subfamily B, Member 1, Doxorubicin and Antineoplastic Agents. Dr. Sikic has published most often in Cancer Res. Dr. Sikic's most frequent co-authors are George A. Fisher, MD, Norman James Lacayo, MD and Derick Hon Man Lau, MD, PhD.
Papers181
Years published2000 to 2024
Dr. Sikic's papers by year, 2012 to 2024
Topics Dr. Sikic writes about most
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Doxorubicin
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Drug Resistance
- Drug Resistance, Multiple
- Tumor Cells, Cultured
- Etoposide
Dr. Sikic's most frequent co-authors
- George A. Fisher, MD17 shared papers
- Norman James Lacayo, MD12 shared papers
- Derick Hon Man Lau, MD, PhD9 shared papers
Recent publications by Dr. Sikic
Cancer Chemother Pharmacol
ATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1Gemtuzumab
Antineoplastic Combined Chemotherapy ProtocolsATP Binding Cassette Transporter, Subfamily BCyclosporins
Adenosine TriphosphatasesAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B
See who Dr. Sikic researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sikic works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Branimir I. Sikic has worked on 8 clinical trials
Dmand AI links Dr. Sikic to 8 clinical trials, 4 of them phase 1 studies. Conditions studied include Rectal Neoplasms, Colonic Neoplasms and Leukemia. Stanford University sponsors the most, 2.
Clinical trials with Dr. Sikic by phase
- 4Phase 1: 4 trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Sikic's trials
- Rectal Neoplasms
- Colonic Neoplasms
- Leukemia
- Margins of Excision
- Neoplasm Metastasis
Investigators on the most trials with Dr. Sikic
- Thomas T. Amatruda, MD1 shared trial
- Stephen M. Ansell, MD1 shared trial
- Joseph M. Beck, MD1 shared trial
Recent clinical trials with Dr. Sikic
Hu5F9-G4
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma (opens in a new tab)
CompletedPhase 3
Neoplasm MetastasisMelanomaDacarbazineMEK162
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers (opens in a new tab)
CompletedPhase 1
Margins of ExcisionMorphological and Microscopic FindingsCDX-1127
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer (opens in a new tab)
CompletedPhase 1
Rectal NeoplasmsColonic NeoplasmsBevacizumabCapecitabineOxaliplatin
Rectal NeoplasmsColonic NeoplasmsCapecitabineCetuximabOxaliplatin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Branimir I. Sikic received $20,855 in industry payments from 2018 to 2020
CMS Open Payments shows 9 general payments to Dr. Sikic from 1 drug or device company from 2018 to 2020. Consulting fees make up the largest share, 100% of the total. Pfizer Inc. paid the most, $20,855.
General payments to Dr. Sikic by program year, 2018 to 2020
Companies that paid Dr. Sikic the most, 2018 to 2020
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Branimir I. Sikic has 1 award and honors on record
Dmand AI lists 1 award for Dr. Sikic, most recently ASCO Fellow in 2010.
Awards and honors for Dr. Sikic
- 2010
- ASCO Fellow
Source: Dmand AI Professional Profile Data
Dr. Branimir I. Sikic graduated from Pritzker School of Medicine
Dr. Sikic graduated from Pritzker School of Medicine in 1972. Dr. Sikic is a member of ACP and ASCO.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Branimir I. Sikic's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Branimir I. Sikic
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Branimir I. Sikic's NPI number?
Dr. Branimir I. Sikic's NPI number is 1376679548. It was assigned on February 24, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Branimir I. Sikic?
Dr. Branimir I. Sikic is a hematologist and oncologist in Stanford, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Branimir I. Sikic practice?
Dr. Sikic practices at 300 Pasteur Dr, Stanford, CA 94305. Dr. Sikic's primary practice is Stanford Hospital in Stanford, California.
What is Dr. Branimir I. Sikic's office phone number?
The practice phone on file for Dr. Sikic is (650) 723-4000.
What is Dr. Branimir I. Sikic's medical license number?
Dr. Sikic's California license number on file is G41273.
Is Dr. Branimir I. Sikic board certified?
Yes. Dr. Sikic is board certified in internal medicine by the American Board of Internal Medicine.
Where did Dr. Branimir I. Sikic go to medical school?
Dr. Sikic graduated from Pritzker School of Medicine in 1972.
Has Dr. Branimir I. Sikic received payments from drug or device companies?
CMS Open Payments shows $20,855 in general payments to Dr. Sikic from 1 company from 2018 to 2020. The largest total came from Pfizer Inc.
How long has Dr. Branimir I. Sikic been practicing?
Dr. Sikic graduated from medical school in 1972, 54 years ago.
Does Dr. Branimir I. Sikic do research?
Dmand AI links 181 publications to Dr. Sikic, published from 2000 to 2024. Dr. Sikic has worked on 8 clinical trials.
Who does Dr. Branimir I. Sikic publish with?
Dr. Sikic's most frequent co-authors are George A. Fisher, MD (17 shared papers), Norman James Lacayo, MD (12 shared papers) and Derick Hon Man Lau, MD, PhD (9 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card